Рецепт. 2018; : 91-101
Научно-практические подходы к управлению конкурентоспособностью аптечных сетей
Аннотация
В статье выделены ключевые компетенции стратегического управления для аптечных сетей, представлено дерево стратегических целей аптечной сети, построена карта стратегических целей с отображением логических взаимосвязей, проведено каскадирование целей и построена карта стратегических задач по структурным подразделениям аптечных сетей.
Список литературы
1. Kaminskaya A.V., Stepanov A.S. (2015) Organizatsionno-metodicheskie osnovyi primeneniya sbalansirovannoy sistemyi pokazateley v deyatelnosti aptechnoy seti [Organizational- methodical bases of application of the balanced system of indicators in the pharmacy network activity]. Remedium, no 5, pp. 45-50.
2. Kotvitska A.A., Surikova I.O. (2014) Analiz faktoriv, shcho vplyvaiut na konkurentospromozhnist vitchyznianykh farmatsevtychnykh pidpryiemstv [Analysis of the factors influencing the competitiveness of domestic pharmaceutical companies]. Modern achievements of pharmaceutical technology: Abstracts оf IV Scientific And Practical Conference With International Participation (Ukraine, Kharkov, October 16-17, 2014), pp. 166-167.
3. Маla Zh.V., Posylkina О.V., Nessonova M.M. (2017) Methodological approaches to the analysis and assessment of marketing competitive advantages of pharmacy networks. Social Pharmacy in Public Health, vol. 3, no 1, pp. 41-51.
4. Mala Ž.V., Posylkina О.V., Nessonova M.M. (2017) Analiz faktoriv vplyvu na dynamiku konkurentospromožnosti aptečnych merež u zaležnosti vid jich typu [Analysis of the factors influencing the dynamics of the competitiveness of pharmacy networks depending on their type]. Management, economics and quality assurance in pharmacy, no 1(49), pp. 57-65.
5. Posylkina O.V., Demčenko N.V. (2014) Metodolohični i metodyčni aspekty ocinky konkurentospromožnosti farmacevtyčnyx pidpryjemstv [Methodological and methodological aspects of assessing the competitiveness of pharmaceutical companies]. Management, economics and quality assurance in pharmacy, no 2, pp. 28-35.
6. Redchenko K. (2004) Balanced Scorecard v farmatsevticheskih kompaniyah: nichego nevozmozhnogo net [Balanced Scorecard in pharmaceutical companies: nothing is impossible]. Remedium, no 5, pp. 51-53.
7. Rogulya O.Yu., Convisar O.M. (2014) Teoretychni aspekty formuvannia ta otsinky konkurentospromozhnosti vyrobnychoho pidpryiemstva [Theoretical Aspects of Formation and Estimation of the Competitiveness of a Production Enterprise]. Professional Management in the Modern Conditions of Market Development: Abstracts оf III Scientific And Practical Conference (Ukraine, Kharkov, November 4, 2014), pp. 306-307.
8. Ryizhkova M., Kolipova Yu. (2003) Strategicheskoe upravlenie farmatsevticheskoy organizatsiey [Strategic management of a pharmaceutical organization]. Remedium, no 7-8, pp. 64-69.
9. Tereshchuk S.I., Hromovyk B.P. (2009) Otsinka konkurentospromozhnosti ekonomichnoho potentsialu aptek [Estimation of the competitiveness of the economic potential of pharmacies]. Provizor, no 19, pp. 2-6.
10. Posylkina О.V., Маla Zh.V., Nessonova M.M. (2017) Prediction of the competitiveness dynamics of pharmacy networks. ScienceRise, no 2(6), pp. 47-52.
Recipe. 2018; : 91-101
Scientific and practical approaches to managing pharmacy’s networks competitiveness
Abstract
References
1. Kaminskaya A.V., Stepanov A.S. (2015) Organizatsionno-metodicheskie osnovyi primeneniya sbalansirovannoy sistemyi pokazateley v deyatelnosti aptechnoy seti [Organizational- methodical bases of application of the balanced system of indicators in the pharmacy network activity]. Remedium, no 5, pp. 45-50.
2. Kotvitska A.A., Surikova I.O. (2014) Analiz faktoriv, shcho vplyvaiut na konkurentospromozhnist vitchyznianykh farmatsevtychnykh pidpryiemstv [Analysis of the factors influencing the competitiveness of domestic pharmaceutical companies]. Modern achievements of pharmaceutical technology: Abstracts of IV Scientific And Practical Conference With International Participation (Ukraine, Kharkov, October 16-17, 2014), pp. 166-167.
3. Mala Zh.V., Posylkina O.V., Nessonova M.M. (2017) Methodological approaches to the analysis and assessment of marketing competitive advantages of pharmacy networks. Social Pharmacy in Public Health, vol. 3, no 1, pp. 41-51.
4. Mala Ž.V., Posylkina O.V., Nessonova M.M. (2017) Analiz faktoriv vplyvu na dynamiku konkurentospromožnosti aptečnych merež u zaležnosti vid jich typu [Analysis of the factors influencing the dynamics of the competitiveness of pharmacy networks depending on their type]. Management, economics and quality assurance in pharmacy, no 1(49), pp. 57-65.
5. Posylkina O.V., Demčenko N.V. (2014) Metodolohični i metodyčni aspekty ocinky konkurentospromožnosti farmacevtyčnyx pidpryjemstv [Methodological and methodological aspects of assessing the competitiveness of pharmaceutical companies]. Management, economics and quality assurance in pharmacy, no 2, pp. 28-35.
6. Redchenko K. (2004) Balanced Scorecard v farmatsevticheskih kompaniyah: nichego nevozmozhnogo net [Balanced Scorecard in pharmaceutical companies: nothing is impossible]. Remedium, no 5, pp. 51-53.
7. Rogulya O.Yu., Convisar O.M. (2014) Teoretychni aspekty formuvannia ta otsinky konkurentospromozhnosti vyrobnychoho pidpryiemstva [Theoretical Aspects of Formation and Estimation of the Competitiveness of a Production Enterprise]. Professional Management in the Modern Conditions of Market Development: Abstracts of III Scientific And Practical Conference (Ukraine, Kharkov, November 4, 2014), pp. 306-307.
8. Ryizhkova M., Kolipova Yu. (2003) Strategicheskoe upravlenie farmatsevticheskoy organizatsiey [Strategic management of a pharmaceutical organization]. Remedium, no 7-8, pp. 64-69.
9. Tereshchuk S.I., Hromovyk B.P. (2009) Otsinka konkurentospromozhnosti ekonomichnoho potentsialu aptek [Estimation of the competitiveness of the economic potential of pharmacies]. Provizor, no 19, pp. 2-6.
10. Posylkina O.V., Mala Zh.V., Nessonova M.M. (2017) Prediction of the competitiveness dynamics of pharmacy networks. ScienceRise, no 2(6), pp. 47-52.
